nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Transient ischaemic attack—Ramipril—type 1 diabetes mellitus	0.0217	0.047	CcSEcCtD
Naratriptan—Balance disorder—Ramipril—type 1 diabetes mellitus	0.02	0.0434	CcSEcCtD
Naratriptan—Burning sensation—Ramipril—type 1 diabetes mellitus	0.0158	0.0341	CcSEcCtD
Naratriptan—Neuralgia—Ramipril—type 1 diabetes mellitus	0.0158	0.0341	CcSEcCtD
Naratriptan—Myocardial ischaemia—Ramipril—type 1 diabetes mellitus	0.0136	0.0295	CcSEcCtD
Naratriptan—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00991	0.0214	CcSEcCtD
Naratriptan—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00919	0.0199	CcSEcCtD
Naratriptan—Polyuria—Ramipril—type 1 diabetes mellitus	0.00906	0.0196	CcSEcCtD
Naratriptan—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00906	0.0196	CcSEcCtD
Naratriptan—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00897	0.0194	CcSEcCtD
Naratriptan—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00889	0.0192	CcSEcCtD
Naratriptan—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00858	0.0186	CcSEcCtD
Naratriptan—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00839	0.0182	CcSEcCtD
Naratriptan—Purpura—Ramipril—type 1 diabetes mellitus	0.00825	0.0179	CcSEcCtD
Naratriptan—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.00822	0.0178	CcSEcCtD
Naratriptan—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00812	0.0176	CcSEcCtD
Naratriptan—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00789	0.0171	CcSEcCtD
Naratriptan—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00734	0.0159	CcSEcCtD
Naratriptan—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00716	0.0155	CcSEcCtD
Naratriptan—Gastritis—Ramipril—type 1 diabetes mellitus	0.00704	0.0152	CcSEcCtD
Naratriptan—Asthma—Ramipril—type 1 diabetes mellitus	0.00688	0.0149	CcSEcCtD
Naratriptan—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.0067	0.0145	CcSEcCtD
Naratriptan—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00661	0.0143	CcSEcCtD
Naratriptan—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00659	0.0143	CcSEcCtD
Naratriptan—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00628	0.0136	CcSEcCtD
Naratriptan—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00604	0.0131	CcSEcCtD
Naratriptan—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00601	0.013	CcSEcCtD
Naratriptan—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00601	0.013	CcSEcCtD
Naratriptan—Sweating—Ramipril—type 1 diabetes mellitus	0.00588	0.0127	CcSEcCtD
Naratriptan—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00575	0.0124	CcSEcCtD
Naratriptan—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00513	0.0111	CcSEcCtD
Naratriptan—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00497	0.0108	CcSEcCtD
Naratriptan—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00492	0.0106	CcSEcCtD
Naratriptan—Alopecia—Ramipril—type 1 diabetes mellitus	0.00486	0.0105	CcSEcCtD
Naratriptan—Erythema—Ramipril—type 1 diabetes mellitus	0.00479	0.0104	CcSEcCtD
Naratriptan—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00461	0.00996	CcSEcCtD
Naratriptan—Tremor—Ramipril—type 1 diabetes mellitus	0.00449	0.00971	CcSEcCtD
Naratriptan—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00444	0.00962	CcSEcCtD
Naratriptan—Agitation—Ramipril—type 1 diabetes mellitus	0.0044	0.00952	CcSEcCtD
Naratriptan—Malaise—Ramipril—type 1 diabetes mellitus	0.00432	0.00935	CcSEcCtD
Naratriptan—Vertigo—Ramipril—type 1 diabetes mellitus	0.0043	0.00931	CcSEcCtD
Naratriptan—Syncope—Ramipril—type 1 diabetes mellitus	0.0043	0.00929	CcSEcCtD
Naratriptan—Palpitations—Ramipril—type 1 diabetes mellitus	0.00423	0.00916	CcSEcCtD
Naratriptan—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00421	0.00911	CcSEcCtD
Naratriptan—Cough—Ramipril—type 1 diabetes mellitus	0.00418	0.00904	CcSEcCtD
Naratriptan—Convulsion—Ramipril—type 1 diabetes mellitus	0.00415	0.00898	CcSEcCtD
Naratriptan—Myalgia—Ramipril—type 1 diabetes mellitus	0.00408	0.00882	CcSEcCtD
Naratriptan—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00408	0.00882	CcSEcCtD
Naratriptan—Anxiety—Ramipril—type 1 diabetes mellitus	0.00406	0.00879	CcSEcCtD
Naratriptan—Discomfort—Ramipril—type 1 diabetes mellitus	0.00403	0.00872	CcSEcCtD
Naratriptan—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00399	0.00863	CcSEcCtD
Naratriptan—Confusional state—Ramipril—type 1 diabetes mellitus	0.00394	0.00853	CcSEcCtD
Naratriptan—Oedema—Ramipril—type 1 diabetes mellitus	0.00391	0.00846	CcSEcCtD
Naratriptan—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00391	0.00846	CcSEcCtD
Naratriptan—Shock—Ramipril—type 1 diabetes mellitus	0.00385	0.00832	CcSEcCtD
Naratriptan—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00383	0.00829	CcSEcCtD
Naratriptan—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00383	0.00828	CcSEcCtD
Naratriptan—Skin disorder—Ramipril—type 1 diabetes mellitus	0.0038	0.00822	CcSEcCtD
Naratriptan—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00378	0.00818	CcSEcCtD
Naratriptan—Hypotension—Ramipril—type 1 diabetes mellitus	0.00365	0.0079	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00356	0.00771	CcSEcCtD
Naratriptan—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00351	0.0076	CcSEcCtD
Naratriptan—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00349	0.00754	CcSEcCtD
Naratriptan—Somnolence—Ramipril—type 1 diabetes mellitus	0.00348	0.00752	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00338	0.0073	CcSEcCtD
Naratriptan—Fatigue—Ramipril—type 1 diabetes mellitus	0.00337	0.00729	CcSEcCtD
Naratriptan—Constipation—Ramipril—type 1 diabetes mellitus	0.00334	0.00723	CcSEcCtD
Naratriptan—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00322	0.00697	CcSEcCtD
Naratriptan—Urticaria—Ramipril—type 1 diabetes mellitus	0.00311	0.00672	CcSEcCtD
Naratriptan—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00309	0.00669	CcSEcCtD
Naratriptan—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00288	0.00623	CcSEcCtD
Naratriptan—Asthenia—Ramipril—type 1 diabetes mellitus	0.00281	0.00607	CcSEcCtD
Naratriptan—Pruritus—Ramipril—type 1 diabetes mellitus	0.00277	0.00598	CcSEcCtD
Naratriptan—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00268	0.00579	CcSEcCtD
Naratriptan—Dizziness—Ramipril—type 1 diabetes mellitus	0.00259	0.00559	CcSEcCtD
Naratriptan—Vomiting—Ramipril—type 1 diabetes mellitus	0.00249	0.00538	CcSEcCtD
Naratriptan—Rash—Ramipril—type 1 diabetes mellitus	0.00247	0.00533	CcSEcCtD
Naratriptan—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00246	0.00533	CcSEcCtD
Naratriptan—Headache—Ramipril—type 1 diabetes mellitus	0.00245	0.0053	CcSEcCtD
Naratriptan—Nausea—Ramipril—type 1 diabetes mellitus	0.00232	0.00502	CcSEcCtD
Naratriptan—HTR1D—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000652	0.00121	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000652	0.00121	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.000649	0.00121	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000648	0.00121	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000647	0.0012	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000646	0.0012	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000638	0.00119	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000638	0.00119	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00063	0.00117	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—HBA2—type 1 diabetes mellitus	0.000627	0.00117	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000613	0.00114	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000609	0.00113	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000606	0.00113	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000606	0.00113	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000602	0.00112	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000602	0.00112	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.0006	0.00112	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000593	0.0011	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—G6PC2—type 1 diabetes mellitus	0.00059	0.0011	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000589	0.00109	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000587	0.00109	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.000585	0.00109	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000567	0.00106	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000567	0.00105	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000566	0.00105	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.000563	0.00105	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.000561	0.00104	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.000556	0.00103	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000556	0.00103	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000555	0.00103	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00055	0.00102	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.000546	0.00101	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000542	0.00101	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000539	0.001	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000535	0.000996	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000515	0.000957	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ABCC8—type 1 diabetes mellitus	0.000511	0.000951	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000508	0.000945	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000504	0.000937	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000503	0.000936	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000501	0.000932	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000498	0.000925	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000495	0.000921	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000494	0.000919	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000492	0.000915	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000487	0.000906	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000486	0.000904	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000486	0.000904	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000485	0.000902	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.00048	0.000893	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000478	0.00089	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000475	0.000884	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000475	0.000884	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000457	0.00085	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000455	0.000847	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000452	0.000841	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000452	0.00084	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00045	0.000837	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000449	0.000835	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000444	0.000825	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000442	0.000823	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000441	0.000819	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000434	0.000808	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000427	0.000794	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000423	0.000787	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000423	0.000786	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000418	0.000777	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SST—type 1 diabetes mellitus	0.000417	0.000776	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000416	0.000773	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000415	0.000771	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000413	0.000769	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00041	0.000763	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000408	0.000759	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000406	0.000755	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000405	0.000753	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000404	0.000752	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000403	0.000749	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000394	0.000733	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000389	0.000724	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000388	0.000721	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000388	0.000721	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000385	0.000716	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000385	0.000716	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000384	0.000714	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000381	0.000709	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.00038	0.000706	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000377	0.000701	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000377	0.000701	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000377	0.0007	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000375	0.000698	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000372	0.000692	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000371	0.00069	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00037	0.000687	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000369	0.000686	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000368	0.000684	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000362	0.000673	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000358	0.000666	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000355	0.000659	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000348	0.000647	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000347	0.000645	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ITPR3—type 1 diabetes mellitus	0.000341	0.000634	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000337	0.000627	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000336	0.000624	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000331	0.000615	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000329	0.000613	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000325	0.000604	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—HBA1—type 1 diabetes mellitus	0.000321	0.000597	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000321	0.000596	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOC3—type 1 diabetes mellitus	0.000319	0.000593	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000318	0.000592	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000318	0.000592	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000316	0.000588	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000316	0.000588	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000315	0.000586	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000314	0.000584	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GSTT1—type 1 diabetes mellitus	0.000313	0.000583	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000309	0.000575	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000309	0.000575	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000308	0.000574	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000306	0.000569	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000304	0.000565	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000304	0.000565	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000303	0.000564	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.0003	0.000559	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.0003	0.000557	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000298	0.000554	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000298	0.000554	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000291	0.000541	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000291	0.00054	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.00029	0.000539	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000289	0.000538	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000288	0.000535	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000287	0.000534	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000287	0.000534	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000287	0.000534	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000285	0.00053	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000281	0.000523	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000281	0.000522	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.00028	0.000521	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000274	0.000509	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00027	0.000502	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000269	0.0005	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SST—type 1 diabetes mellitus	0.000267	0.000496	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000266	0.000494	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000265	0.000493	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000263	0.000489	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SST—type 1 diabetes mellitus	0.000261	0.000486	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00026	0.000484	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GCG—type 1 diabetes mellitus	0.00025	0.000464	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000242	0.000451	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000239	0.000445	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000238	0.000442	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000236	0.000438	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000233	0.000433	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000229	0.000426	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000228	0.000424	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000227	0.000422	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000227	0.000422	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000224	0.000417	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000222	0.000414	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000222	0.000412	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000221	0.000411	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000218	0.000405	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000217	0.000404	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000217	0.000404	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000214	0.000398	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CAT—type 1 diabetes mellitus	0.000211	0.000393	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—INS—type 1 diabetes mellitus	0.000209	0.000389	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000202	0.000376	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000202	0.000376	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000201	0.000375	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000201	0.000374	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SST—type 1 diabetes mellitus	0.000199	0.00037	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000198	0.000369	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000198	0.000368	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000197	0.000367	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000194	0.000361	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CD86—type 1 diabetes mellitus	0.00019	0.000353	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000187	0.000347	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000185	0.000345	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000184	0.000342	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000183	0.000341	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000181	0.000337	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.00018	0.000335	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000177	0.00033	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000175	0.000325	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000172	0.00032	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000171	0.000318	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000171	0.000318	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.00017	0.000315	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000168	0.000313	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000168	0.000313	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000166	0.000309	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000166	0.000309	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000165	0.000308	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000165	0.000306	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000156	0.000289	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000155	0.000289	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000155	0.000288	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000151	0.00028	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.00015	0.000279	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000145	0.000269	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000141	0.000263	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—INS—type 1 diabetes mellitus	0.00014	0.000261	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000139	0.000258	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000138	0.000257	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000137	0.000255	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—INS—type 1 diabetes mellitus	0.000134	0.000249	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—INS—type 1 diabetes mellitus	0.000131	0.000243	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000131	0.000243	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.00013	0.000243	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000129	0.00024	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000129	0.000239	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ALB—type 1 diabetes mellitus	0.000129	0.000239	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000128	0.000239	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000127	0.000235	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000126	0.000235	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000126	0.000234	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000125	0.000233	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—NOS3—type 1 diabetes mellitus	0.000123	0.000229	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000119	0.000222	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000119	0.000221	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000117	0.000218	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000117	0.000217	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000115	0.000213	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000106	0.000196	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	9.97e-05	0.000185	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.95e-05	0.000185	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL2—type 1 diabetes mellitus	9.94e-05	0.000185	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.89e-05	0.000184	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.75e-05	0.000181	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL2—type 1 diabetes mellitus	9.73e-05	0.000181	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.68e-05	0.00018	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.65e-05	0.000179	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.6e-05	0.000178	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6—type 1 diabetes mellitus	9.14e-05	0.00017	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.91e-05	0.000166	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.75e-05	0.000163	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.36e-05	0.000156	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.19e-05	0.000152	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.6e-05	0.000141	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.44e-05	0.000138	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.42e-05	0.000138	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	7.41e-05	0.000138	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.38e-05	0.000137	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.24e-05	0.000116	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6—type 1 diabetes mellitus	5.84e-05	0.000109	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6—type 1 diabetes mellitus	5.72e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.67e-05	0.000105	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	4.36e-05	8.1e-05	CbGpPWpGaD
